Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $133.98 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $123.04 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $10.94 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $133.98 | 2 | Merck Sharp & Dohme Corporation ($123.04) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/14/2019 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Food and Beverage | In-kind items and services | $123.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/07/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.94 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 838 | 1,059 | $398,060 | $69,057 |
| 2022 | 15 | 783 | 1,022 | $384,286 | $63,793 |
| 2021 | 17 | 811 | 1,030 | $415,041 | $72,682 |
| 2020 | 14 | 566 | 701 | $436,702 | $73,624 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 223 | $122,650 | $25,056 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 205 | $76,875 | $15,739 | 20.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 75 | $38,925 | $5,408 | 13.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $35,892 | $5,295 | 14.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 39 | $27,885 | $4,228 | 15.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $33,984 | $3,791 | 11.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $14,000 | $2,382 | 17.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $10,080 | $1,572 | 15.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 28 | $7,560 | $1,191 | 15.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 77 | 82 | $5,740 | $818.83 | 14.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 29 | 32 | $6,560 | $791.12 | 12.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 73 | 76 | $5,624 | $662.84 | 11.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 80 | 85 | $3,995 | $640.71 | 16.0% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 27 | 33 | $3,597 | $584.14 | 16.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 43 | 57 | $1,170 | $478.80 | 40.9% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 12 | 13 | $1,638 | $255.58 | 15.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $1,885 | $163.44 | 8.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 171 | $94,050 | $19,414 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 129 | 201 | $75,375 | $15,198 | 20.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 36 | $50,976 | $6,544 | 12.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 60 | 98 | $50,862 | $6,342 | 12.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $35,892 | $5,113 | 14.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 25 | $17,875 | $2,310 | 12.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $12,600 | $2,246 | 17.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 56 | 64 | $12,792 | $1,474 | 11.5% |
About Dr. Ezra Dweck, M.D
Dr. Ezra Dweck, M.D is a Pulmonary Disease healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104042886.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ezra Dweck, M.D has received a total of $133.98 in payments from pharmaceutical and medical device companies, with $133.98 received in 2019. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($133.98).
As a Medicare-enrolled provider, Dweck has provided services to 2,998 Medicare beneficiaries, totaling 3,812 services with total Medicare billing of $279,157. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location New York, NY
- Active Since 04/18/2007
- Last Updated 09/11/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1104042886
Products in Payments
- ZINPLAVA (Biological) $123.04
- ELIQUIS (Drug) $10.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in New York
Dr. Bisher Akil, M.d, M.D
Pulmonary Disease — Payments: $452,539
David Rapoport, M.d, M.D
Pulmonary Disease — Payments: $366,853
Peter Bach, Md, MD
Pulmonary Disease — Payments: $358,604
Jonathan Raskin, M.d, M.D
Pulmonary Disease — Payments: $323,538
Roxana Sulica, M.d.,, M.D.,
Pulmonary Disease — Payments: $269,071
Monica Kraft
Pulmonary Disease — Payments: $235,232